Genetic analysis of heparan sulfate in vascular biology
硫酸乙酰肝素在血管生物学中的遗传分析
基本信息
- 批准号:7510385
- 负责人:
- 金额:$ 28.48万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:AcetylgalactosamineAdoptive TransferAllelesAllergic Contact DermatitisAlteplaseAnabolismAntithrombinsArtsBindingBinding SitesBiochemicalBiological AssayBiologyBleeding time procedureBlood Chemical AnalysisBlood VesselsBlood coagulationBone Marrow TransplantationBreedingCellsCharacteristicsChondroitin Sulfate AChondroitin SulfatesCutaneousDeacetylaseDefectDepressed moodDermalDermatan SulfateDevelopmentDisaccharidesEndopeptidasesEndothelial CellsEndotheliumEnzyme Inhibitor DrugsEnzyme InhibitorsEnzymesEvaluationEventExonsExtracellular MatrixExtracellular Matrix ProteinsFamilyFibrinolysisFibroblast Growth FactorFibroblast Growth Factor 2FibroblastsGene DeletionGenesGenetic RecombinationGenomicsGlucuronic AcidGlucuronic AcidsGlycosaminoglycansGoalsGrowth FactorHematologyHemostatic functionHeparan Sulfate ProteoglycanHeparinHeparin BindingHeparitin SulfateHistologyIduronic AcidIn VitroInfectionInflammationInflammatory ResponseInorganic SulfatesInterventionInvasiveIsoenzymesLaboratoriesLeukocytesLibrariesLigandsModelingModificationMolecularMusMutant Strains MiceMutationNumbersOxazolonePenetrancePeptide HydrolasesPeritonitisPharmacologic SubstancePhysiologyPlasminogen InactivatorsPlayPrincipal InvestigatorProgram Research Project GrantsProtein CProtein-Carbohydrate InteractionProteoglycanPurposeRangeReactionRelative (related person)ReporterRoleSerpinsSiteSkinStagingStreptococcus pyogenesStructureSystemTFPITechniquesTechnologyTestingThioglycolatesThrombusTimeTissuesTransfectionTransgenic MiceUnspecified or Sulfate Ion SulfatesWound HealingangiogenesisblastocystcDNA Librarychemokinecytokineembryonic stem cellepimeraseepimerizationgenetic analysisheparan sulfate L-iduronyl 2-O-sulfotransferaseheparan sulfate-N-deacetylase-N-sulfotransferasein vivokeratinocyte growth factormature animalmembermutantneutrophilnull mutationprogramsresearch studysulfationsulfotransferasetoolvector
项目摘要
Endothelial cells express heparan sulfate proteoglycans that bind to plasma and extracellular matrix proteins through carbohydrate-protein interactions. These interactions have led to the hypothesis that endothelial cell proteoglycans play important roles in vascular biology and hemostasis. The objective of this project is to test this idea by genetically altering endothelial HS
in mice. The specific genes that will be studied include two N-deacetylase/N-sulfotransferase isozymes (NDST1 and NDST2) that initiate the modification reactions, the uronosyl 2-O-sulfotransferase (HS2OST) and glucosaminyl 6-O-sulfotransferase-1 (HS6OST1), which generate the binding sites for ligands on the chains. Systemic inactivation of NDST1 and HS2OST in mice have shown that they are essential for early development, making it difficult to assess their role in physiology in adult animals. Therefore, our plan consists of examining mutant mice with selective endothelial-cell null mutations in these genes, using the Cre-loxP recombination system. Mutant alleles of NDST1 have already been made, and targeting of HS2OST and HS6OST1 are in different stages of development. Targeted deletion of these genes in
endothelial cells and leukocytes will be accomplished by breeding to Tie2Cre mice. For each mutant, the degree of penetrance of the mutations will be assessed in isolated cells, and the proteoglycan and glycosaminoglycan composition will be analyzed. Bone marrow transplantation and adoptive transfer experiments will allow us to study heparan sulfate in both the endothelium and in leukocytes. To examine the role of heparan sulfate in hemostasis, blood coagulation, thrombus formation and fibrinolysis will be examined, with particular emphasis on heparin-binding proteinases (Protein C and tissue plasminogen activator) and serpins (antithrombin, tissue factor pathway inhibitor, and plasminogen activator inhibitor-I).
Initial experiments indicate that the bleeding time is altered in NDST1 deficient mice, which may reflect alterations in one or more of these factors. Inflammatory responses appear to be depressed in the mutant as well, in models of thioglycollate-induced peritonitis, oxazolone-induced allergic contact dermatitis, and excisional wound healing. To study these systems further, the effect of altering heparan sulfate on P- and Lselectin and neutrophil chemokines KC and MIP-2 will be examined. The long range goal of these studies is
to determine the role of heparan sulfate in vascular biology, with the purpose of defining potential targets for pharmaceutical intervention.
内皮细胞通过碳水化合物 - 蛋白质相互作用表达与血浆和细胞外基质蛋白结合的肝蛋白聚糖。这些相互作用导致了一个假设,即内皮细胞蛋白聚糖在血管生物学和止血中起重要作用。该项目的目的是通过基因改变内皮HS来测试这一想法
在老鼠中。 The specific genes that will be studied include two N-deacetylase/N-sulfotransferase isozymes (NDST1 and NDST2) that initiate the modification reactions, the uronosyl 2-O-sulfotransferase (HS2OST) and glucosaminyl 6-O-sulfotransferase-1 (HS6OST1), which generate the binding sites for ligands on the链。 NDST1和HS2OST在小鼠中的全身失活表明,它们对于早期发育至关重要,因此很难评估它们在成年动物中的生理学作用。因此,我们的计划包括使用CRE-LoxP重组系统在这些基因中检查具有选择性内皮细胞无效突变的突变小鼠。 NDST1的突变等位基因已经制造,HS2OST和HS6OST1的靶向处于不同的发展阶段。这些基因的目标缺失
内皮细胞和白细胞将通过繁殖到扎2切小鼠来完成。对于每个突变体,将在分离的细胞中评估突变的渗透率,并将分析蛋白聚糖和糖胺聚糖组成。骨髓移植和产卵实验将使我们能够在内皮和白细胞中研究硫酸盐。为了检查硫酸乙酰肝素在止血中的作用,将检查血液凝结,血栓形成和纤维蛋白溶解,特别强调肝素结合蛋白酶(蛋白C和组织纤溶酶原激活剂)和蛇毒蛋白酶(抗凝结物,抗凝结物,组织因子因子途径途径途径途径抑制剂,纤溶酶蛋白激活剂Inbimogentor-i Inbibintor-i)。
最初的实验表明,在NDST1缺乏的小鼠中,出血时间发生了变化,这可能反映了其中一个或多个因素的改变。在突变体中,炎症反应似乎也抑制了硫代糖果诱导的腹膜炎,恶唑酮诱导的过敏性接触性皮炎和解除伤口愈合的模型。为了进一步研究这些系统,将研究改变硫酸乙酰肝素对P-和Lselectin和中性粒细胞趋化因子KC和MIP-2的影响。这些研究的远距离目标是
确定硫酸乙酰肝素在血管生物学中的作用,目的是确定药物干预的潜在靶标。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jeffrey D Esko其他文献
Jeffrey D Esko的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jeffrey D Esko', 18)}}的其他基金
UCSD Biomedical Scientist Career Development Program in Glycoscience
加州大学圣地亚哥分校糖科学生物医学科学家职业发展计划
- 批准号:
10439513 - 财政年份:2018
- 资助金额:
$ 28.48万 - 项目类别:
Glycosylation of the perineuronal net in Alzheimer's Disease
阿尔茨海默病中神经周围网络的糖基化
- 批准号:
9785861 - 财政年份:2018
- 资助金额:
$ 28.48万 - 项目类别:
UCSD Biomedical Scientist Career Development Program in Glycoscience
加州大学圣地亚哥分校糖科学生物医学科学家职业发展计划
- 批准号:
10197205 - 财政年份:2018
- 资助金额:
$ 28.48万 - 项目类别:
PROJECT 3 - Infection-Induced Remodeling of the Vascular Proteome
项目 3 - 感染诱导的血管蛋白质组重塑
- 批准号:
10171430 - 财政年份:2016
- 资助金额:
$ 28.48万 - 项目类别:
Project 3: Heparan Sulfate Proteoglycans in the Pathogenesis of Sepsis
项目3:硫酸乙酰肝素蛋白多糖在脓毒症发病机制中的作用
- 批准号:
9072755 - 财政年份:2016
- 资助金额:
$ 28.48万 - 项目类别:
PROJECT 3 - Infection-Induced Remodeling of the Vascular Proteome
项目 3 - 感染诱导的血管蛋白质组重塑
- 批准号:
10641853 - 财政年份:2016
- 资助金额:
$ 28.48万 - 项目类别:
PROJECT 3 - Infection-Induced Remodeling of the Vascular Proteome
项目 3 - 感染诱导的血管蛋白质组重塑
- 批准号:
10475614 - 财政年份:2016
- 资助金额:
$ 28.48万 - 项目类别:
Genome-wide Analysis of Heparan Sulfate using CRISPR/Cas9
使用 CRISPR/Cas9 对硫酸乙酰肝素进行全基因组分析
- 批准号:
9103016 - 财政年份:2015
- 资助金额:
$ 28.48万 - 项目类别:
Drug Discovery for Multiple Hereditary Exostoses
多种遗传性外生骨疣的药物发现
- 批准号:
8912269 - 财政年份:2013
- 资助金额:
$ 28.48万 - 项目类别:
Drug Discovery for Multiple Hereditary Exostoses
多种遗传性外生骨疣的药物发现
- 批准号:
8735612 - 财政年份:2013
- 资助金额:
$ 28.48万 - 项目类别:
相似海外基金
The role of SH2B3 in regulating CD8 T cells in Type 1 Diabetes
SH2B3 在 1 型糖尿病中调节 CD8 T 细胞的作用
- 批准号:
10574346 - 财政年份:2023
- 资助金额:
$ 28.48万 - 项目类别:
Time to ATTAC: Adoptive Transfer of T cells Against gp100+ Cells to treat LAM
ATTAC 时间:针对 gp100 细胞的 T 细胞过继转移来治疗 LAM
- 批准号:
10682121 - 财政年份:2023
- 资助金额:
$ 28.48万 - 项目类别:
Alpha-Synuclein-Specific T cells in Parkinson's Disease Pathogenesis
帕金森病发病机制中的α-突触核蛋白特异性 T 细胞
- 批准号:
10752172 - 财政年份:2023
- 资助金额:
$ 28.48万 - 项目类别:
Defining astrovirus-specific T cell responses
定义星状病毒特异性 T 细胞反应
- 批准号:
10667003 - 财政年份:2023
- 资助金额:
$ 28.48万 - 项目类别:
Next generation T cell therapies for mutant KRAS solid tumors
针对突变 KRAS 实体瘤的下一代 T 细胞疗法
- 批准号:
10731929 - 财政年份:2023
- 资助金额:
$ 28.48万 - 项目类别: